DCGI grants approval to vaccines of Serum Institute of India, Bharat Biotech

2021-01-03 14

Drugs Controller General of India VG Somani on January 03 informed that Covid-19 vaccines of Serum Institute of India and Bharat Biotech have been granted permission for restricted use in an emergency situation.

Videos similaires

COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddys Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials

DCGI grants approves vaccines of Serum Institute of India, Bharat Biotech

Vaccines of Serum Institue of India and Bharat Biotech are granted permission for restricted use in emergency situation: DCGI | TV9News | D2-H-19

Covid vaccine: DCGI approves Serum, Bharat Biotech vaccines for emergency use

DCGI approves Serum, Bharat Biotech vaccines for emergency use

DCGI approves Serum, Bharat Biotech vaccines for emergency use | Oneindia Malayalam

Covishield of Serum Institute,Covaxin of Bharat Biotech get DCGI approval as coronavirus vaccines_D4-H-21

DCGI approves Serum, Bharat Biotech vaccines for emergency use_ Know what people have to say _ D10-H25

India Approves Two COVID-19 Vaccines: Oxford-Serum Institute's Covishield & Bharat Biotech's Covaxin Receives Emergency Approval From DCGI

COVID-19 Vaccine Update: Covaxin By Bharat Biotech Cleared For Phase 3 Trials By The Drugs Controller General Of India (DCGI)

Web Analytics